An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: The REPOSE study

  1. Ahmed, F.
  2. Gaul, C.
  3. Garciá-Moncó, J.C.
  4. Sommer, K.
  5. Martelletti, P.
Revue:
Journal of Headache and Pain

ISSN: 1129-2377,  1129-2369

Année de publication: 2019

Volumen: 20

Número: 1

Type: Article

DOI: 10.1186/S10194-019-0976-1 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus